Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cyteir Therapeutics Inc
(NQ:
CYT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cyteir Therapeutics Inc
< Previous
1
2
3
Next >
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2021
July 13, 2021
Upgrades For Royal Dutch Shell PLC (NYSE:RDS), Bar...
Via
Benzinga
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
July 11, 2021
Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback...
Via
Benzinga
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts
July 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE...
Via
Benzinga
Exposures
Product Safety
Cyteir Therapeutics Announces Closing of Initial Public Offering
June 22, 2021
From
Cyteir Therapeutics
Via
Business Wire
55 Biggest Movers From Friday
June 28, 2021
Gainers IKONICS Corporation (NASDAQ: IKNX) shares surged 64.3% to close at $18.56 on Friday after the company reported a merger deal with TeraWulf. Alpha Teknova, Inc. (NASDAQ:...
Via
Benzinga
Opening Day: WalkMe Stock Price Falls Following $287M IPO
June 19, 2021
Backed by Insight Venture Partners, WalkMe fell as much as 7% in its trading debut earlier this week after a $287M initial public offering. According to filings, Insight will remain WalkMe's biggest...
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Cyteir Therapeutics Announces Pricing of Initial Public Offering
June 17, 2021
From
Cyteir Therapeutics, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.